Hermes Investment Management’s Gilead Sciences GILD Stock Holding History

Hermes Investment Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$1.63M	Hold	23,016	–	–	0.02%	158
2018 Q1	$1.74M	Buy	23,016 +1,000	+5%	+$79.5K	0.03%	158
2017 Q4	$1.58M	Buy	22,016 +1,200	+6%	+$91.1K	0.02%	161
2017 Q3	$1.69M	Buy	20,816 +2,091	+11%	+$160K	0.03%	151
2017 Q2	$1.32M	Hold	18,725	–	–	0.02%	151
2017 Q1	$1.27M	Hold	18,725	–	–	0.02%	148
2016 Q4	$1.34M	Buy	18,725 +1,500	+9%	+$111K	0.02%	154
2016 Q3	$1.36M	Hold	17,225	–	–	0.02%	155
2016 Q2	$1.44M	Hold	17,225	–	–	0.03%	155
2016 Q1	$1.62M	Hold	17,225	–	–	0.03%	155
2015 Q4	$1.74M	Hold	17,225	–	–	0.04%	154
2015 Q3	$1.69M	Hold	17,225	–	–	0.04%	145
2015 Q2	$2.02M	Hold	17,225	–	–	0.05%	149
2015 Q1	$1.69M	Buy	17,225 +2,100	+14%	+$213K	0.04%	158
2014 Q4	$1.43M	Buy	15,125 +12,000	+384%	+$1.24M	0.04%	156
2014 Q3	$333K	Sell	3,125 -39,500	-93%	-$3.87M	0.01%	212
2014 Q2	$3.53M	Sell	42,625 -334,889	-89%	-$26.1M	0.1%	135
2014 Q1	$26.8M	Buy	+377,514	New	+$29.6M	0.84%	62

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Hermes Investment Management's GILD Position: Q2 2018 in Review

Hermes Investment Management held its Gilead Sciences (GILD) position steady in Q2 2018 at 23,016 shares worth $1.63M. The position accounts for 0.02% of the portfolio, ranked #158.

Hermes Investment Management first reported a position in GILD in Q1 2014 and has held it in 18 quarters since. The position peaked at $26.8M in Q1 2014. 1,522 funds tracked by Wall St. Rank hold GILD as of Q2 2018.

Hermes Investment Management held 23,016 shares of Gilead Sciences worth $1.63M as of Q2 2018.
Hermes Investment Management left its Gilead Sciences share count unchanged in Q2 2018.
Gilead Sciences made up 0.02% of Hermes Investment Management's portfolio in Q2 2018, its #158 holding.
Hermes Investment Management first reported a position in Gilead Sciences in Q1 2014 and has held it in 18 quarters since.
Hermes Investment Management's Gilead Sciences position peaked at $26.8M in Q1 2014.
1,522 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2018.

Based on Hermes Investment Management's 13F filing for Q2 2018, filed 24 Jul 2018.